Trevi Therapeutics Aktie
8,38
USD
-0,17
USD
-1,99
%
8,39
USD
-0,16
USD
-1,81
%
Werbung
Trevi Therapeutics Aktie Analyse
03.06.19 | Trevi Therapeutics Outperform | BMO Capital Markets | |
03.06.19 | Trevi Therapeutics Buy | Needham & Company, LLC |
Werbung
Werbung